Level of knowledge of the nursing professional when applying tissue plasminogen activator in patients with STROKE.
Nivel de conocimiento del profesional de enfermería al aplicar el activador plasminógeno tisular en pacientes con ICTUS
DOI:
https://doi.org/10.51422/ren.v20i2.335Keywords:
Ischaemic stroke, Fibrinolysis, Trhombolysis, Alteplase, Care nursingAbstract
Introduction:The treatment with recombinant activator of the tissue plasminógeno (English abbreviation in rt-PA), applied by intravenous route (VIV) is the procedure of forward edge in cases of attack of cerebrovascular acute (ACVA) in a window of 4.5 hours from the beginning of the symptoms of ACVA and with low risk of hemorrágica transformation of the infarct cerebra. Even, in a recent metaanálisis, this beneficial effect stays in spite of the age, superior to 80 years and of independent form of the size of the cerebral infarct. 4,5Este work tries to inspect the level of knowledge of the personnel of infirmary in the care and the application of the recombinant activator of the tissue plasminógeno (rt-PA) in susceptible patients with ictus of fibrinolítico treatment in an institution of third level. With the purpose Of implementing the registry code ictus in the service of urgencies of the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez, and of outlining the guide of performance in the infirmary professionals.
General objective: To inspect the level of knowledge of the personnel of infirmary in the care and the application of the recombinant activator of the tissue plasminógeno (rt-PA) in the Ictus, the service of urgencies.
Hypothesis: If the level of knowledge of the infirmary personnel is adapted in the service of urgencies, then the patients will diminish the neurological sequels to the maximum and possible added complications.
Methodology: It was made a observacional and cross-sectional study in the National Institute of Neurology and Neurosurgery Manuel Velasco Suárez of the City of Mexico, with a sampling by convenience participated 33 professionals of infirmary who toil in the service of Urgencies, were observed the 24 hours of the day. Between the inclusion criteria it was taken into account to nurses of all the categories, was excluded medical personnel, substitute stretcher-bearers and nurses. An instrument was applied to evaluate the knowledge that has the nurse of the isquémica vascular disease, as well as for the interventions of infirmary in the immediate and mediate care in the administration of the drug Tissue Activator of Plasminógeno
Results: This study in which the level of knowledge of professionals of infirmary in an institution of third level is valued, calls the attention that single 58%de the population knows the time vital to recover to the brain, another data that alarms is that 30% of the population do not know clearly the concept of Ictus and to the being an institution of neurological specialty of must take action to revert these calculations. Discussion: The paper of the professionals of infirmary in units specialized in neurological affections to the patients with ictus is to provide a care of quality, effective and efficient, besides to participate in the integral valuation of the patient and in the administration of the Actilyse when it is a fibrinolítica therapy. He is by that the nurse must be formed on the cuidaos that east type of patients, the own complications of the pathology requires, treatment and indirect effect of mimo. To propose an integral plan of cares, because already the personnel has knowledge on the matter of the disease and the application of the tissue activator, but would be interesting to implement for the professionals in formation, as well as a proposal is made as guide of performance.
Downloads
References
R. Calvo Rodríguez, J.J. Ochoa Sepúlveda, et.al. Accidente cerebrovascular,2018. Elsevier España, S.L.U. Reservados todos los derechos. Descargado para Anonymous User (n/a) en National Autonomous University of México de ClinicalKey.es por Elsevier en abril 12, 2021. Disponible en: https://www-clinicalkey-es.pbidi.unam.mx:2443/#!/content/book/3-s2.0-B9788491134954000451?scrollTo=%23hl0000430
Organización Mundial de la Salud. Enfermedades Cardiovasculares. [citado 8 de marzo 2021]. Disponible en: https://t.ly/jsu1
Arauz Antonio, Ruíz-Franco Angélica. Enfermedad vascular cerebral. Rev. Fac. Med. (Méx.) [revista en la Internet]. 2012 Jun [citado 2021 abril 08] ; 55( 3 ): 11-21. Disponible en: https://t.ly/EHIm
PINEDA, David A. Trombólisis con activador recombinante del plasminógeno tisular (rt-PA) para el ataque cerebro vascular agudo: la experiencia colombiana. Acta Neurol Colomb. [online]. 2017, vol.33, n.1, pp.1-2. ISSN 0120-8748. https://t.ly/s0b4 . DOI: https://doi.org/10.22379/24224022121
Hacke W, Donnan G, Fieschi C; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 6;363(9411):768-74. DOI:10.1016/S0140-6736(04)15692-4. PMID: 15016487. Disponible en: https://t.ly/EtAt
García-Dorta M., “Cuidados de enfermería: ictus isquémico y fibrinólisis. Facultad de Ciencias de la Salud, Sección de Enfermería Universidad de la Laguna CURSO 2017/2018, Grado de Enfermería. [citado abril 12 2021] Disponible en: https://t.ly/KO7s
Cantú-Brito C., Ruiz-Sandoval J.L., Murillo-Bonilla L.M., Chiquete E., León-Jiménez C., Arauz A., Villarreal-Careaga J., Rangel-Guerra R., Ramos-Moreno A., Manejo agudo y pronóstico a un año en pacientes mexicanos con un primer infarto cerebral: resultados del estudio multicéntrico PREMIER. Rev. Neurol. 2010; 51:641-649. [citado abril 16 2021] Disponible en: vhttps://t.ly/XhTt DOI: https://doi.org/10.33588/rn.5111.2010527
Secretaría de Salud: Gobierno del estado de Puebla, Día mundial de la Enfermedad Vascular Cerebral. Miércoles 24 de julio 2020, [citado abril 18 2021], Disponible en: http://ss.puebla.gob.mx/prevencion/informate/item/860-dia-mundial-de-la-enfermedad-vascular-cerebral
Torres-Arreola LDP, Valenzuela-Flores AA, Villa-Barragán JP. Caracterización de los pacientes con EVC atendidos en hospitales del IMSS en la Ciudad de México [Characterization of stroke patients attended at IMSS hospitals in Mexico City]. Rev Med Inst Mex Seguro Soc. 2018 Jan-Feb;56(1):18-25. Spanish. PMID: 29368891. Disponible en: https://t.ly/3pyN
Barinagarrementeria Aldatz, F. C., & Arauz Gongora Antonio, Terapéutica de la enfermedad vascular cerebral. Editorial Alfil, segunda edición, Médico Ciudad de México, 2011, pp. 39-41, [citado abril 19 2021] Disponible en: https://t.ly/bdXK
Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007 Jan 27;369(9558):275-82. DOI: 10.1016/S0140-6736(07)60149-4 . rratum in: Lancet. 2007 Mar 10;369(9564):826. PMID: 17258667. https://t.ly/tPz9 DOI: https://doi.org/10.1016/S0140-6736(07)60149-4
Cué Brugueras Manuel. Agentes trombolíticos en el infarto agudo del miocardio. Rev Cubana Farm [Internet]. 1995 Ago [citado 2021 abril 14] ; 29( 2 ). Disponible en: https://t.ly/KGyC
Cantú-Brito C, Ruiz-Sandoval JL, Arauz-Góngora A, et al. Prevalencia de estenosis carotídea en pacientes con isquemia cerebral transitoria en México. Rev Mex Neuroci. 2010;11(5):343-348. [citado 2021 abril 14] Disponible en: https://t.ly/GBB6
Romero Cortés I, Guzmán Morales AG, Islas Ruz FG. Trombólisis exitosa en la enfermedad cerebrovascular: reporte de un caso. Revista de Sanidad Militar [Internet]. 2018 Sep [cited 2021 Apr 12];72(5/6):359–62. Available from: https://t.ly/ktp4
OMS. (2013). Recuperado el 6 de Julio de 2013, de http://www.who.int/about/es/ Organization, W. H. (9 de Octubre de 2014). www.whoint/topics/cerebrovascular_accident/en. Recuperado el 9 de octubre de 2014, de www.whoint/topics/cerebrovascular
Murillo-Bonilla LM, Lizola-Hernández J, Lepe-Cameros L, Ruiz-SandovalJL, Erwin Chiquete, et al, por los investigadores del estudio RENAMEVASC. Factores predictivos de discapacidad funcional y muer-te a 30 días en sujetos con infarto cerebral agudo: Resultados del Registro Nacional Mexicano de Enfermedad Vascular Cerebral (EstudioRENAMEVASC). Rev Mex Neuroci 2011; 12: 68-75. [citado 2021 abril 14] Disponible en: https://t.ly/M7NR
Beltrán-Rodríguez I, Tejada-García J, Durán-Borrella O, Rodrigo-Stevens G, García-Vieitez JJ. Ictus vertebrobasilar: registro de tiempos de asistencia y factores relacionados con la atención precoz [Vertebrobasilar stroke: recording of care times and factors related to early care]. Rev Neurol. 2020 Nov 1;71(9):326-334. Spanish. DOI: 10.33588/rn.7109.2020089 PMID: 33085077. https://t.ly/ZESn DOI: https://doi.org/10.33588/rn.7109.2020089
Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S; ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 6;363(9411):768-74. • DOI: 10.1016/S0140-6736(04)15692-4 PMID: 15016487. https://t.ly/Rvfe DOI: https://doi.org/10.1016/S0140-6736(04)15692-4
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999 Dec 1;282(21):2019-26. DOI: 10.1001/jama.282.21.2019 . PMID: 10591384. https://t.ly/q7Qn DOI: https://doi.org/10.1001/jama.282.21.2019
Zhang X, Wang A, Zhang JY, Jia B, Huo X, Zuo Y, Tian X, Wang Y, Miao Z; BAST study investigators. Efficacy and safety of butylphthalide for patients who had acute ischaemic stroke receiving intravenous thrombolysis or endovascular treatment (BAST trial): study protocol for a randomised placebo-controlled trial. BMJ Open. 2021 May 25;11(5):e045559. doi: DOI: 10.1136/bmjopen-2020-045559 . PMID: 34035100; PMCID: PMC8154958. https://t.ly/LluW DOI: https://doi.org/10.1136/bmjopen-2020-045559
Foro Ictus; Asociación madrileña de Neurología. Atención a los pacientes con ictus en la comunidad de Madrid. Servicio Madrileño de Salud. 2014. Disponible en: https://t.ly/37zg
Emberson J, Lees KR, Lyden P, Blackwell L, ALbers G, Bluhmki E, et al. Effect of tratment delay, age and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29;384(9958):1929-35. DOI: 10.1016/S0140-6736(14)60584-5 . Epub 2014 Aug 5. PMID: 25106063; PMCID: PMC4441266. https://t.ly/Or9x DOI: https://doi.org/10.1016/S0140-6736(14)60584-5
Alonso de Leciñana A, Elegido JA, Casado I, Ribó M, Dávalos A, Masjuan J et al. Guidelines for the treatment of acute ischaemic stroke. Neurología (Barc., Ed. impr.) ; 29(2): 102-122, mar. 2014. Tab Article Es | IBECS | ID: ibc-119452 [citado 2021 abril 14] Disponible en: https://t.ly/OvsL
Consejo General de Colegios Oficiales de Farmacéuticos. Guía práctica ictus. 2017. Disponible en: http://www.portalfarma.com/
Andrés Marcos R. Efectividad del tratamiento fibrinolítico en el ictus isquémico [Trabajo final de grado]. Universidad de Valladolid; 2017. [citado 2021 abril 14] Disponible en: https://t.ly/DXPP
Kjellström T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis. 2007;23(2-3):231-41. DOI: 10.1159/000097646 . Epub 2006 Nov 30. PMID: 17139166. https://t.ly/eECu DOI: https://doi.org/10.1159/000097646
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista de Enfermería Neurológica

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.